Utility of Serum Vascular Endothelial Growth Factor and Its Clinico-Histopathological Correlation With Cervical Cancer: A Tertiary Care Centre Study
Shashikant, Ram Raghuvanshi, Mustafa Ali, Hukam Meena, Radhika Rai, Pankaj Shinde · 2026
Read Utility of Serum Vascular Endothelial Growth Factor and Its Clinico-Histopathological Correlation With Cervical Cancer: A Tertiary Care Centre Study by Shashikant, Ram Raghuvanshi, Mustafa Ali, Hukam Meena, Radhika Rai, Pankaj Shinde (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13501858.txt.
Description
Shashikant leads a six-author team reporting a 2026 hospital study of a blood marker in cervical cancer at a centre in Indore, India. Vascular endothelial growth factor, VEGF, drives the new blood vessels tumours need, so its blood level might betray tumour burden. Over twelve months the pathology department enrolled fifty diagnosed, untreated patients whose cancer was confirmed by tissue examination. Serum VEGF was measured by ELISA, and levels were set against tumour grade, type, and clinical and tissue features.
Levels ran above normal across the group, averaging 670.89 picograms per millilitre. The marker climbed as tumour grade rose, tying it to how aggressive the cancer looked under the microscope. No clear link appeared with the histological type of tumour. The authors propose serum VEGF as a non-invasive prognostic aid for sorting patients by severity and watching treatment response, while calling for larger studies to confirm the role.
Catalog record
| CREATOR | Shashikant, Ram Raghuvanshi, Mustafa Ali, Hukam Meena, Radhika Rai, Pankaj Shinde |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |